B

휴마시스

205470KOSDAQ의료용품 및 기타 의약 관련제품 제조업

63.0 / 100

Reference Date: 2026-06-10

Financial Score28.5 / 40
News Sentiment12.5 / 25
Momentum12.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 252.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

HumaSys operates in three main business segments: POCT immunoassay reagents for in vitro diagnostics, production of male condoms and medical devices, and entertainment services. The POCT division focuses on improving diagnostic products for COVID-19 and HIV, while the rubber products division produces a range of items according to international standards. The entertainment division generates revenue through artist management and content production. Major revenue streams come from POCT (13.4%), rubber products (19.5%), and entertainment services (46.2%).

Number of Employees

64people

Average Salary

47.6M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 19.194.0Point
PBR
0.30Industry Average 1.307.0Point

Half of industry avg (excellent)

ROE
-8.97Industry Average -4.893.5Point

1.8x industry avg (good)

Debt Ratio
0.35Industry Average 6.868.0Point

Half of industry avg (excellent)

Trend 2023~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲51.1% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲39.9% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -13.2% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Detailed Momentum

52-week position5.0Point

52w mid range (59%)

Current 2,825Won52-week high 4,26552-week low 682
1-month return6.0Point

1m +252.68% (strong rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

10 totalPositive 0Neutral 10Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-06-05
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-05
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-29
  • Neutral주식등의대량보유상황보고서(일반)2026-05-29
  • Neutral주식등의대량보유상황보고서(일반)2026-05-22